Feline GI Lymphoma: Small-Cell vs Large-Cell Immunophenotype

Two Different Cancers Under One Name

Feline gastrointestinal lymphoma is the most common form of lymphoma in cats in the post-vaccination era. The name describes a location, not a single disease. Within feline GI lymphoma sit two very different cancers: small-cell GI lymphoma, an indolent low-grade T-cell process that closely mimics inflammatory bowel disease, and large-cell GI lymphoma, an aggressive high-grade cancer with B-cell or T-cell phenotype that demands very different treatment. The prognosis and the treatment plan diverge dramatically based on which entity is present, and accurate distinction at diagnosis is one of the most important contributions a board-certified veterinary pathologist (DACVP) can make for a cat with chronic GI signs.

This article walks through how the two subtypes are recognized, how the diagnostic workup separates them, and what families can expect from each treatment pathway. The contrast is one of the textbook examples of how immunophenotype changes everything in modern veterinary oncology.

How Small-Cell Lymphoma Presents

Small-cell GI lymphoma usually develops in middle-aged to older cats with chronic, insidious signs. Weight loss is often the dominant complaint, sometimes preceded or accompanied by intermittent vomiting, soft stool or diarrhea, and gradually declining appetite. Many owners describe the signs as having gone on for months before veterinary attention, because the cat continues to act largely normal between episodes.

Physical examination findings can include palpable thickening of intestinal loops, mesenteric lymphadenopathy in some cats, and a body condition that has dropped over time. Bloodwork is often unremarkable or shows mild changes such as cobalamin (vitamin B12) deficiency and elevated total T4 (when concurrent hyperthyroidism is present). The clinical picture overlaps significantly with chronic inflammatory bowel disease (IBD), which is exactly why definitive diagnosis requires histopathology and additional immunophenotyping.

How Large-Cell Lymphoma Presents

Large-cell GI lymphoma typically presents more dramatically. Cats may have rapidly progressive weight loss over weeks rather than months, persistent vomiting, anorexia, palpable abdominal mass, lethargy, and sometimes acute abdominal pain or intestinal obstruction. Bloodwork findings can include anemia, hypoalbuminemia from protein-losing enteropathy, and elevated liver enzymes when hepatic involvement is present.

The contrast in clinical pace is one of the first clues that points toward large-cell versus small-cell disease, although definitive distinction requires tissue diagnosis. Cats with large-cell GI lymphoma often arrive at the veterinarian in a more compromised state than those with small-cell disease.

Diagnostic Workup

Initial workup includes complete blood count, chemistry panel, urinalysis, total T4, FeLV and FIV testing, cobalamin and folate levels, abdominal radiographs, and abdominal ultrasound. Ultrasound is the most useful imaging modality for evaluating intestinal wall thickness, layering, and regional lymphadenopathy. Diffuse thickening of the muscularis layer is suggestive of small-cell lymphoma, while focal mass lesions or marked transmural thickening suggest large-cell disease.

Tissue diagnosis is the cornerstone. Endoscopic mucosal biopsies sample only the inner layer of the intestine and frequently miss small-cell lymphoma that lives deeper in the wall. Full-thickness surgical biopsies, obtained via exploratory laparotomy, are widely considered the gold standard for diagnosis of small-cell GI lymphoma because they sample all layers of the intestinal wall and allow accurate distinction from IBD. The DACVP performs histopathology with immunohistochemistry for CD3, CD20, CD79a, and Ki-67 proliferation index, and flow cytometry or PARR PCR is added on samples when available.

Our flow cytometry and PARR PCR article details the molecular tools, and the WHO REAL classification article covers the broader subtype framework.

Treatment for Small-Cell GI Lymphoma

Small-cell GI lymphoma responds well to a combination of oral prednisolone and chlorambucil, an oral alkylating agent. The protocol is well-tolerated, can be administered at home with periodic recheck examinations, and produces clinical remission in the majority of cats. Owners often report substantial improvement in appetite, weight, and overall demeanor within several weeks of starting therapy.

Published median survival times for cats with small-cell GI lymphoma treated with chlorambucil and prednisolone commonly fall in the range of 12-24 months in peer-reviewed case series, with significant individual variation. Many cats live longer; some respond less durably. The DACVIM-Oncology specialist directs the specific protocol, including dosing schedule, monitoring bloodwork, and supportive care. Our chlorambucil for cats reference covers the drug-specific framework.

Supportive Care for Small-Cell Disease

Supportive care often includes cobalamin (vitamin B12) supplementation for cats with documented deficiency, antiemetic therapy as needed for nausea or vomiting, and appetite stimulants such as mirtazapine or capromorelin when intake remains poor. Many cats stabilize and gain weight with the combination of chemotherapy and supportive care.

Cobalamin supplementation in particular is one of the most impactful adjuncts for cats with chronic small intestinal disease. Many cats with small-cell lymphoma have low serum cobalamin at diagnosis, and supplementation often produces noticeable improvement in appetite and energy. The DACVIM-Oncology specialist or internal medicine team monitors cobalamin levels and adjusts the supplementation schedule.

Treatment for Large-Cell GI Lymphoma

Large-cell GI lymphoma is treated with CHOP-based combination chemotherapy, modified for feline physiology. The protocol combines cyclophosphamide, doxorubicin, vincristine, and prednisolone in rotating cycles under DACVIM-Oncology supervision. Response rates are lower than for canine multicentric DLBCL, but many cats achieve clinical remission with significant improvement in symptoms.

Published median survival times for cats with large-cell GI lymphoma treated with CHOP-based protocols are typically in the range of 6-9 months in peer-reviewed series, again with wide individual variation. Some cats respond exceptionally well; others have limited response. The DACVIM-Oncology specialist sets realistic expectations during the initial consultation and adjusts the plan based on response to induction.

The large-cell lymphoma in cats reference covers the broader treatment context for adopters and families navigating a new diagnosis.

The induction phase of CHOP-based therapy is more demanding on cats than the maintenance phase that follows. Owners commit to weekly or biweekly visits during induction, with regular bloodwork to monitor for neutropenia and other toxicities. Cats who tolerate induction well typically transition into a less intensive maintenance schedule that fits more easily into the family’s routine.

The IBD-to-Lymphoma Question

One of the longest-running discussions in feline gastroenterology is whether chronic IBD progresses to small-cell GI lymphoma over time, or whether the two conditions are distinct entities that overlap clinically. The current understanding is that some cats with chronic IBD do develop small-cell lymphoma, possibly through chronic immune stimulation and clonal selection. The practical implication is that any cat with chronic GI signs that fail to respond to IBD-directed therapy should be reassessed with full-thickness biopsies and immunophenotyping.

This is the principal reason that the DACVIM-Oncology and internal medicine community has moved toward earlier definitive diagnosis rather than open-ended dietary and medical trials. Distinguishing IBD from small-cell lymphoma changes the treatment and prognosis conversation entirely.

Monitoring and Long-Term Care

Cats on chlorambucil-prednisolone therapy for small-cell lymphoma are typically rechecked at intervals of one to three months with physical examination, weight monitoring, body condition scoring, CBC, and chemistry. The DACVIM-Oncology specialist adjusts the protocol based on tolerance and response. Many cats remain stable on the same protocol for a year or more before any change is needed.

Cats undergoing CHOP-based chemotherapy for large-cell disease require more intensive monitoring during induction, with frequent CBC checks for neutropenia and ongoing assessment of response. The intensity decreases once the cat reaches the maintenance phase.

Cost and Specialty Access

Diagnostic workup for feline GI lymphoma including ultrasound, full-thickness biopsy with anesthesia, histopathology, and immunohistochemistry typically totals several thousand dollars. Chlorambucil-prednisolone therapy for small-cell disease is among the more affordable cancer treatment pathways in veterinary oncology because the drugs are inexpensive and most administration is at home. CHOP-based therapy for large-cell disease is meaningfully more expensive due to the IV chemotherapy administration and monitoring schedule.

If a DACVIM-Oncology specialist is not available in your region, your primary veterinarian can often administer chlorambucil-prednisolone protocols under telemedicine supervision after the initial diagnosis and plan are established. CHOP-based chemotherapy is more typically delivered at a specialty oncology practice. Our treatment cost realism guide covers planning frameworks for families weighing their options.

Some primary veterinary practices have the infrastructure to deliver modified CHOP-based protocols under telemedicine oncology supervision. The decision rests on the available staffing, infusion capability, and the comfort level of both the primary practice and the supervising specialist. The path that fits the family’s logistics often determines whether full CHOP, a modified protocol, or chlorambucil-prednisolone is the right plan.

Adoption-Positive Framing

A cat diagnosed with small-cell GI lymphoma can often live many additional months to years with good quality of life on a simple, well-tolerated home-administered chemotherapy protocol. Adopters who take on cats with small-cell lymphoma are providing exactly the kind of patient, structured care that this disease rewards. Even cats with large-cell GI lymphoma can experience meaningful improvement with chemotherapy, and adopters working with a DACVIM-Oncology team have realistic options for supported care during the remaining time. Our GI lymphoma in cats reference serves as a useful adopter-facing companion.

What Adopters Should Know Before Committing

Adopters considering a cat with confirmed or suspected GI lymphoma benefit from understanding the realistic treatment commitment. Small-cell disease requires daily or every-other-day oral medication, periodic recheck visits, cobalamin supplementation in many cats, and ongoing nutritional support. Large-cell disease requires more intensive chemotherapy scheduling during induction.

Cats with small-cell GI lymphoma often look and act remarkably normal once on a stable treatment regimen. The chemotherapy is delivered at home, the recheck schedule is manageable, and many cats live for months to years in good condition. Adopters who go in with realistic expectations and a connection to a DACVIM-Oncology team often report an excellent experience providing supported care.

Frequently Asked Questions

How do I know if my cat has IBD or small-cell lymphoma?

Definitive distinction requires full-thickness intestinal biopsy with immunohistochemistry and often PARR PCR. Endoscopic mucosal biopsies frequently miss the diagnosis. If your cat has chronic GI signs that fail to respond to IBD-directed treatment, ask your veterinarian about referral for full-thickness biopsy.

Is chlorambucil-prednisolone really effective for small-cell lymphoma?

Yes. Published case series report clinical response in the majority of treated cats with median survival commonly in the 12-24 month range. The protocol is well-tolerated and most administration is at home, which makes it practical for many families.

Will my cat lose hair on chemotherapy?

Cats generally lose less hair on chemotherapy than dogs or humans. Some thinning of whiskers and slight coat changes can occur. Most cats look essentially normal during treatment.

Can large-cell GI lymphoma be treated without CHOP?

Some families choose less aggressive protocols when CHOP is not feasible due to cost, distance from specialty care, or quality-of-life priorities. Options include single-agent prednisolone with palliative intent or modified protocols. Median survival is typically shorter than with full CHOP-based therapy, and the DACVIM-Oncology specialist will discuss realistic expectations.

Can small-cell GI lymphoma transform to large-cell?

Yes, transformation to a higher-grade disease is described in some cats over time. Any sudden change in clinical course in a cat on chlorambucil therapy should prompt re-evaluation including possible repeat biopsy.